Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Vetter Managing Director to Retire | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Vetter Managing Director to Retire

Thomas Otto will step down at the end of 2025 after more than 35 years with the company.

By: Rachel Klemovitch

Assistant Editor

Vetter, a globally leading CDMO, announced the retirement of its Managing Director, Thomas Otto, after over 35 years at the company. He will step down at the end of 2025.

Through his leadership and commitment, Otto has helped shape the sustainable development and continued growth of the company. 

During the transition period, Otto will serve in an advisory role, where he will consult on the planned development of a new production site in Germany.

Long-term experienced Vetter executives Henryk Badack, Titus Ottinger, and Carsten Press were appointed to the Management Board as Managing Directors at the beginning of 2025. 

With their in-depth understanding of the company, its customers, and the industry, they are making a significant contribution to Vetter’s sustainable future and the trust towards the owner family and the company Advisory Board.

“[Thomas Otto’s] contribution to Vetter’s development and internationalization is outstanding and deserves the highest recognition,” says Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family. “For more than three decades, he was a reliable designer, initiator and bridge builder – both within the company and externally. On behalf of the Vetter family and the advisory board, I would like to thank him for his extraordinary commitment and lasting impact on our success story.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics